CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

189 hedge funds and large institutions have $1.61B invested in Cymabay Therapeutics in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+38
Holders Change %
+25.17%
% of All Funds
3.01%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.19%
New
63
Increased
57
Reduced
52
Closed
24
Calls
$35M
Puts
$32.9M
Net Calls
+$2.15M
Net Calls Change
-$1.47M
Name Holding Trade Value Shares
Change
Shares
Change %
Mackenzie Financial
201
Mackenzie Financial
Ontario, Canada
-$417K -35,660 Closed
CC
202
Centiva Capital
New York
-$255K -23,300 Closed
LCM
203
LVM Capital Management
Michigan
-$252K -23,000 Closed
BAM
204
Blueshift Asset Management
New Jersey
-$213K -19,413 Closed
Capstone Investment Advisors
205
Capstone Investment Advisors
New York
-$209K -19,124 Closed
JIC
206
Johnson Investment Counsel
Ohio
-$197K -18,000 Closed
BHCM
207
Boulder Hill Capital Management
New York
-$194K -17,700 Closed
TSS
208
Two Sigma Securities
New York
-$181K -16,517 Closed
ACM
209
Aquatic Capital Management
Illinois
-$81K -7,400 Closed
HCA
210
Harbor Capital Advisors
Illinois
-$51.5K -4,701 Closed
GWS
211
Glassman Wealth Services
Virginia
-$11 -1 Closed